Futu News reported on December 23 that $QINGSONG HEALTH (02661.HK)$ The stock opened higher on the first day, surging 120.46%. As of press time, it was trading at HKD 50 per share. Each lot consists of 200 shares, and excluding handling fees, a profit of HKD 5,464 can be made per lot.
Source of market data: Futu Securities
According to previous reports, in the pre-market trading session conducted by Futu on the last trading day, Easy Health closed up 127.95% at HKD 51.7 per share. Each lot consists of 200 shares, and excluding handling fees, investors gained HKD 5,804 per lot.
Additionally, according to earlier public disclosures, during the public offering phase, Easy Health received subscriptions totaling 1,421.47 times the available shares. The final number of shares allocated for public offering amounted to 2.654 million shares, representing approximately 10% of the total shares offered. A total of approximately 111,900 valid applications were received, with 12,338 applications processed. The approximate percentage of the total applied-for shares allotted to those who subscribed for one lot was 6%.
Furthermore, during the international placement phase, Easy Health's shares were oversubscribed by 2.9 times. The final number of shares allocated under the international placement was 23.886 million, equivalent to 90% of the total shares offered.
Company Overview
Easy Health provides digital integrated health services and health insurance solutions in China. According to data from the Frost & Sullivan report, the company ranks tenth in China's digital integrated health services and health insurance services market by revenue in 2024. Specifically, according to the same source, Easy Health ranks seventh in China’s digital health services market by revenue in 2024. The company is committed to providing accessible, precise, and affordable health solutions to offer protection and support to those in need.
The company serves users seeking comprehensive health solutions with health-related services, including promotional activities and consultations related to early disease screening, health check-ups and consultations, medical appointment services, and the sale of health supplements. All users are individuals who can access the company’s services through its WeChat Official Account, mini-programs, Enterprise WeChat accounts, and website. As an integral part of the company’s services, it also empowers industry participants to create high-quality scientific content in the form of digital marketing and promotes public health initiatives, ultimately empowering key participants in the industry value chain, including medical institutions, practitioners, and researchers.
Financial Overview
In terms of financial performance, the company’s revenue for the years 2022, 2023, and 2024, as well as for the six months ended June 30, 2024, and June 30, 2025, amounted to RMB 393.6 million, RMB 490 million, RMB 945 million, RMB 355.2 million, and RMB 656.1 million, respectively. The company recorded profits from continuing operations during the periods of 2023 and 2024, as well as for the six months ended June 30, 2024, and June 30, 2025, amounting to RMB 97.2 million, RMB 9 million, RMB 14.6 million, and RMB 86 million, respectively. For the years 2022, 2023, and 2024, as well as for the six months ended June 30, 2024, and June 30, 2025, the company’s adjusted net profits were RMB 149.2 million, RMB 146.6 million, RMB 84.4 million, RMB 46 million, and RMB 51.2 million, respectively.
The prime season for subscribing to new shares has arrived! Use Futu to subscribe to new shares with 0 interest, 0 handling fees, and 0 cash subscription. Participants in the current promotion have the chance to waive one year’s fees for subscribing to new shares.Come and experience it now >>
Note: This activity is exclusively available to users in the Hong Kong region.
Editor/Joe